3 October 2022
| Rohan Misra, Ciara O’Byrne, Pearse A Keane (Prof)
|
Ophthalmology
A new focus has arisen within the research domain of artificial intelligence (AI) in healthcare called code-free deep learning (CFDL), and recent research demonstrates that ophthalmology is becoming one of the leading specialties in this field. Artificial intelligence (AI) is...
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are scientific reality and which are ‘fake news’. Headline: “Robot performs cataract surgery on patient!” Twenty-five years ago when Eye News launched, a news headline such...
Decades have passed and the influence of analysing fundus images by grading consultants and retinal image specialists has grown worldwide. Their job is to specialise in assessing hundreds of diagnosed eye disease disorders and to read thousands of eye images,...
When I was a junior doctor in the late 1990s writing my first scientific papers, once each article was finished, I had to fill out an application form, print out multiple copies and then walk to the post office at...
New accents, friendly smiles and haggis served with my traditional morning breakfast, I knew at this point that I was a long way from the south of England, where this story begins.
It would have been hard to miss all the attention chatbots have received over the last few months. Whilst ChatGPT is easily the most well-known example of the large language models that have become so widespread of late, artificial intelligence...
In recent issues we reviewed the OrCam MyEye Pro, a glasses mounted mobile device that can assist sight impaired users. This time we are taking a look at the Envision Glasses, a comparable device that takes a different approach (see...
AI was a hot topic at the 18th Congress of the European Society of Retina Specialists (EURETINA), following the publication of important findings in relation to using this technology in diagnosing retinal disease. We were delighted to catch Pearse Keane,...
Diabetic retinopathy (DR) is a complication of diabetes, caused by high blood sugar levels damaging the retinal microvasculature. Mechanisms, such as oxidative stress and deposition of advanced glycation end products, leads to glial cell activation and neuronal apoptosis. Pericytes, contractile...